Phosphorylation and stabilization of EZH2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer
Nikhil B Ghate1, Sungmin Kim1, Yonghwan Shin1
1Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, 90033, USA.
Abstract:
Our recent work has shown that DCAF1 (also known as VprBP) is overexpressed in colon cancer and phosphorylates histone H2AT120 to drive epigenetic gene inactivation and oncogenic transformation. We have extended these observations by investigating whether DCAF1 also phosphorylates non-histone proteins as an additional mechanism linking its kinase activity to colon cancer development. We now demonstrate that DCAF1 phosphorylates EZH2 at T367 to augment its nuclear stabilization and enzymatic activity in colon cancer cells. Consistent with this mechanistic role, DCAF1-mediated EZH2 phosphorylation leads to elevated levels of H3K27me3 and altered expression of growth regulatory genes in cancer cells. Furthermore, our preclinical studies using organoid and xenograft models revealed that EZH2 requires phosphorylation for its oncogenic function, which may have therapeutic implications for gene reactivation in colon cancer cells. Together, our data define a mechanism underlying DCAF1-driven colonic tumorigenesis by linking DCAF1-mediated EZH2 phosphorylation to EZH2 stability that is crucial for establishing H3K27me3 and gene silencing program.
Insights
DCAF1 protein promotes colon cancer by phosphorylating EZH2, increasing its stability and gene-silencing activity. This finding offers potential therapeutic strategies for colon cancer by targeting EZH2 reactivation.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- DCAF1 (VprBP) is overexpressed in colon cancer, where it drives oncogenesis via histone phosphorylation.
- The role of DCAF1 in phosphorylating non-histone proteins in colon cancer remains unexplored.
Purpose of the Study:
- To investigate if DCAF1 phosphorylates non-histone proteins in colon cancer.
- To elucidate the mechanism by which DCAF1 influences colon cancer development through non-histone protein phosphorylation.
Main Methods:
- Western blotting and immunoprecipitation to detect protein phosphorylation.
- Quantitative PCR and RNA sequencing to analyze gene expression.
- Organoid and xenograft models for preclinical validation.
Main Results:
- DCAF1 phosphorylates EZH2 at threonine 367 (T367) in colon cancer cells.
- Phosphorylation enhances EZH2's nuclear stability and enzymatic activity.
- DCAF1-mediated EZH2 phosphorylation increases H3K27me3 levels and alters growth-regulatory gene expression.
- Preclinical models confirm EZH2 phosphorylation is essential for its oncogenic function.
Conclusions:
- DCAF1-mediated EZH2 phosphorylation stabilizes EZH2, promoting H3K27me3 and gene silencing in colon cancer.
- This mechanism highlights a novel pathway in DCAF1-driven tumorigenesis.
- Targeting EZH2 phosphorylation presents a potential therapeutic strategy for colon cancer gene reactivation.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Anaphase Promoting Complex
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
DNA Damage can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules


